Inhaled insulin: Phase IIa data

In a German Phase IIa trial in 24 insulin-naïve patients, inhaled insulin gave a mean reduction of blood glucose of 28% compared to 23% for insulin glargine. Inhaled insulin treatment resulted in 10% ...